VALITOR
Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Their technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. They currently have three development pipelines in the fields of dermatology, ophthalmology, and orthopedics that highlight the capabilities of their novel drug products.
VALITOR
Social Links:
Industry:
Biotechnology Developer Tools Medical Therapeutics
Founded:
2010-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.valitorbio.com
Total Employee:
1+
Status:
Active
Contact:
(510) 969-9246
Email Addresses:
[email protected]
Total Funding:
38.97 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Tag Manager Google Analytics LetsEncrypt SSL By Default Global Site Tag HSTS Google Analytics 4
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
HepaTx
Hepatx is developing regenerative medicine solutions.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Tilden Bio
Tilden Bio develops photosynthetic bioproducts including natural plant essential oils, cannabinoids, and biopharmaceutical proteins.
Urban Mining Company
Urban Mining Company develops a proprietary Magnet-to-Magnetärecycling process.
Visgenx
Visgenx develops therapeutics to protect against the loss of sight from retinal disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
First Spark Ventures
First Spark Ventures investment in Series B - Valitor
ExSight Ventures
ExSight Ventures investment in Series B - Valitor
Morningside Venture Investments
Morningside Venture Investments investment in Series B - Valitor
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Series B - Valitor
Pandect Bioventures
Pandect Bioventures investment in Series B - Valitor
SVE Capital
SVE Capital investment in Series A - Valitor
Phaenomena West Capital
Phaenomena West Capital investment in Series A - Valitor
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Series A - Valitor
Z-Gen Capital
Z-Gen Capital investment in Series A - Valitor
Berkeley SkyDeck Fund
Berkeley SkyDeck Fund investment in Series A - Valitor
Official Site Inspections
http://www.valitorbio.com
- Host name: ec2-34-192-255-123.compute-1.amazonaws.com
- IP address: 34.192.255.123
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Valitor"
Leadership | VLTR-557 | AMD | Valitor - valitorbio.com
Valitor is engineering disruptive medicines that optimize how and where disease mechanisms are targeted to produce the most significant clinical impact. VLTR-557, is in development to …See details»
Valitor - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (510) 969-9246 Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve …See details»
Valitor - LinkedIn
Valitor, Inc. is a biotechnology company founded to develop advanced, protein-based drugs. Using our core technology, we can modify existing biological therapies to achieve substantial control ...See details»
Valitor Company Profile | Management and Employees List
Www.valitorbio.com . Valitor Profile and History. Valitor, Inc. is a biotechnology company founded to develop advanced, protein-based drugs. Using our core technology, we can modify existing …See details»
Valitor Company Profile - Office Locations, Competitors ... - Craft
Valitor $29.72 m in total funding,. See insights on Valitor including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
10-05-22 Press Release | Valitor - valitorbio.com
Oct 5, 2022 Valitor, Inc. 2956 San Pablo Ave Berkeley, CA 94702 Phone: (510) 969-9246 Fax: (510) 647-8429See details»
Valitor - Products, Competitors, Financials, Employees, …
Headquarters Location. 2630 Bancroft Avenue . Berkeley, California, 94704, United States. 510-545-6062See details»
Valitor - Overview, News & Similar companies | ZoomInfo.com
Oct 5, 2022 Valitor contact info: Phone number: (510) 545-6062 Website: www.valitorbio.com What does Valitor do? Valitor, Inc. is a biotechnology company founded to develop advanced, …See details»
Valitor, Inc. | F6S
Valitor, Inc. - Valitor, Inc. is a biotechnology company founded to develop advanced, protein-based drugs. Using our core technology, we can modify existing biological therapies to …See details»
VALITOR, INC. - VentureRadar
"Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity.See details»
Valitor- Engineering better medicines by leveraging its multi …
Dec 13, 2022 - https://www.valitorbio.com - Decision making process to launch Valiant Bio - Working with faculty at UC Berkeley to spin out a technology - Multivalent Polymer conjugation …See details»
Valitor - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 12, 2025 Email ID: *****@valitorbio.com; Key Metrics. Total Funding. $38.2M in 4 rounds. Latest Funding Round. Series B, Oct 06, 2022, $28M. Investors. Morningside & 9 more. …See details»
Valitor Raises $28M Series B to Develop Therapy for Age ... - Bakar …
The company will spend next year testing its multivalent polymer to prep for a clinical trial in 2024. The goal is to create an injectable that can last six months, meaning patients with wet AMD, a …See details»
Valitor Information - RocketReach
Valitorbio.com; 1 408466XXXX; Adrien Krupenkin Research Associate - Chemistry at Valitor San Francisco, CA, US View. View Similar People. Related Companies WIREWORKS WEST, INC. …See details»
Valitor, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Prior to that, he was Chief Commercial Officer of Corcept Therapeutics Incorporated, where he established the commercial organization to launch the company’s first product. Earlier in his …See details»
Press Releases | Valitor - valitorbio.com
July 19, 2023 Valitor Expands Leadership Team with Appointment of Omkar Joshi, Ph.D. as Vice President of CMC. April 24, 2023 Valitor Presents Preclinical Data on its Long-acting Anti …See details»
Valitor Company Overview, Contact Details & Competitors | LeadIQ
Oct 5, 2022 Valitor launched data from VLTR-557 on Apr 25th '23. Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced new data …See details»
Valitor - LifeScienceHistory.com
Company Info Phone (510) 969-9246 Year Established 1983. Contacts William S. White, R.Ph., M.B.A. CDOSee details»
Valitor Bio - Berkeley Startup Cluster
Developer of new generation drugs designed to improve the current treatment strategies for a variety of diseases. The company’s drugs act within a targeted diseased tissue and modify …See details»
Working At Valitor: Company Overview and Culture - Zippia
Learn about working at Valitor from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more.See details»